Transpedal vs. femoral access for peripheral arterial interventions—A single center experience

Sooraj M. Shah, Anna Bortnick, Olivier F. Bertrand, Olivier Costerousse, Wah W. Htun, Tak W. Kwan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To compare the transpedal approach to established femoral approach for endovascular treatment of infrainguinal peripheral arterial disease. Background: Endovascular treatment of infrainguinal peripheral arterial disease is on the rise. Femoral approach is widely used but has significant complications. Recently the primary transpedal approach has been described for endovascular interventions. We hypothesized that transpedal approach could reduce access site related complications. We compared the two approaches in a retrospective cross-sectional study at a single center. Methods: We analyzed demographics, procedural parameters, and complications in patients who underwent a primary transpedal approach for infrainguinal intervention and compared to patients with a traditional femoral approach in our outpatient based endovascular lab. Results: The success rate for access was lower in transpedal group compared to femoral (94% vs. 100%, p =.0002). The contrast dose (44 ± 11 mL vs. 68 ± 13 mL, p <.0001), radiation dose (25 mGy [16–43] vs. 48 mGy [36–67], p <.0001) and fluoroscopy time (5.48 min [3.48–11.71] vs. 9.35 min [6.63–14.11], p <.0001) were significantly lower in transpedal group. Conclusion: The transpedal approach for infrainguinal revascularization appears to be a reasonable primary approach with high success and low complication rate with significant reduction in radiation and contrast dose. These findings should be further studied in a randomized controlled trial.

Original languageEnglish (US)
JournalCatheterization and Cardiovascular Interventions
DOIs
StatePublished - Jan 1 2019

Fingerprint

Thigh
Peripheral Arterial Disease
Radiation
Fluoroscopy
Outpatients
Randomized Controlled Trials
Cross-Sectional Studies
Demography
Therapeutics

Keywords

  • COMV—complications
  • ENDI—endovascular intervention
  • PAD—peripheral arterial disease
  • vascular access

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Transpedal vs. femoral access for peripheral arterial interventions—A single center experience. / Shah, Sooraj M.; Bortnick, Anna; Bertrand, Olivier F.; Costerousse, Olivier; Htun, Wah W.; Kwan, Tak W.

In: Catheterization and Cardiovascular Interventions, 01.01.2019.

Research output: Contribution to journalArticle

@article{5455eb23d83f4bf0a2c3e4e57d96fc13,
title = "Transpedal vs. femoral access for peripheral arterial interventions—A single center experience",
abstract = "Objective: To compare the transpedal approach to established femoral approach for endovascular treatment of infrainguinal peripheral arterial disease. Background: Endovascular treatment of infrainguinal peripheral arterial disease is on the rise. Femoral approach is widely used but has significant complications. Recently the primary transpedal approach has been described for endovascular interventions. We hypothesized that transpedal approach could reduce access site related complications. We compared the two approaches in a retrospective cross-sectional study at a single center. Methods: We analyzed demographics, procedural parameters, and complications in patients who underwent a primary transpedal approach for infrainguinal intervention and compared to patients with a traditional femoral approach in our outpatient based endovascular lab. Results: The success rate for access was lower in transpedal group compared to femoral (94{\%} vs. 100{\%}, p =.0002). The contrast dose (44 ± 11 mL vs. 68 ± 13 mL, p <.0001), radiation dose (25 mGy [16–43] vs. 48 mGy [36–67], p <.0001) and fluoroscopy time (5.48 min [3.48–11.71] vs. 9.35 min [6.63–14.11], p <.0001) were significantly lower in transpedal group. Conclusion: The transpedal approach for infrainguinal revascularization appears to be a reasonable primary approach with high success and low complication rate with significant reduction in radiation and contrast dose. These findings should be further studied in a randomized controlled trial.",
keywords = "COMV—complications, ENDI—endovascular intervention, PAD—peripheral arterial disease, vascular access",
author = "Shah, {Sooraj M.} and Anna Bortnick and Bertrand, {Olivier F.} and Olivier Costerousse and Htun, {Wah W.} and Kwan, {Tak W.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/ccd.28209",
language = "English (US)",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Transpedal vs. femoral access for peripheral arterial interventions—A single center experience

AU - Shah, Sooraj M.

AU - Bortnick, Anna

AU - Bertrand, Olivier F.

AU - Costerousse, Olivier

AU - Htun, Wah W.

AU - Kwan, Tak W.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: To compare the transpedal approach to established femoral approach for endovascular treatment of infrainguinal peripheral arterial disease. Background: Endovascular treatment of infrainguinal peripheral arterial disease is on the rise. Femoral approach is widely used but has significant complications. Recently the primary transpedal approach has been described for endovascular interventions. We hypothesized that transpedal approach could reduce access site related complications. We compared the two approaches in a retrospective cross-sectional study at a single center. Methods: We analyzed demographics, procedural parameters, and complications in patients who underwent a primary transpedal approach for infrainguinal intervention and compared to patients with a traditional femoral approach in our outpatient based endovascular lab. Results: The success rate for access was lower in transpedal group compared to femoral (94% vs. 100%, p =.0002). The contrast dose (44 ± 11 mL vs. 68 ± 13 mL, p <.0001), radiation dose (25 mGy [16–43] vs. 48 mGy [36–67], p <.0001) and fluoroscopy time (5.48 min [3.48–11.71] vs. 9.35 min [6.63–14.11], p <.0001) were significantly lower in transpedal group. Conclusion: The transpedal approach for infrainguinal revascularization appears to be a reasonable primary approach with high success and low complication rate with significant reduction in radiation and contrast dose. These findings should be further studied in a randomized controlled trial.

AB - Objective: To compare the transpedal approach to established femoral approach for endovascular treatment of infrainguinal peripheral arterial disease. Background: Endovascular treatment of infrainguinal peripheral arterial disease is on the rise. Femoral approach is widely used but has significant complications. Recently the primary transpedal approach has been described for endovascular interventions. We hypothesized that transpedal approach could reduce access site related complications. We compared the two approaches in a retrospective cross-sectional study at a single center. Methods: We analyzed demographics, procedural parameters, and complications in patients who underwent a primary transpedal approach for infrainguinal intervention and compared to patients with a traditional femoral approach in our outpatient based endovascular lab. Results: The success rate for access was lower in transpedal group compared to femoral (94% vs. 100%, p =.0002). The contrast dose (44 ± 11 mL vs. 68 ± 13 mL, p <.0001), radiation dose (25 mGy [16–43] vs. 48 mGy [36–67], p <.0001) and fluoroscopy time (5.48 min [3.48–11.71] vs. 9.35 min [6.63–14.11], p <.0001) were significantly lower in transpedal group. Conclusion: The transpedal approach for infrainguinal revascularization appears to be a reasonable primary approach with high success and low complication rate with significant reduction in radiation and contrast dose. These findings should be further studied in a randomized controlled trial.

KW - COMV—complications

KW - ENDI—endovascular intervention

KW - PAD—peripheral arterial disease

KW - vascular access

UR - http://www.scopus.com/inward/record.url?scp=85063628359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063628359&partnerID=8YFLogxK

U2 - 10.1002/ccd.28209

DO - 10.1002/ccd.28209

M3 - Article

C2 - 30920716

AN - SCOPUS:85063628359

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

ER -